Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XX
- Chemical substanceL01XX05Hydroxycarbamide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Netherlands
CBG-MEB · 9 registrations
- Hydroxycarbamide Devatis 500mg, harde capsulesCapsule, hard · Devatis GmbH
- Hydroxycarbamide ERC 500 mg, harde capsulesCapsule, hard · Euro Registratie Collectief B.V.
- Hydroxycarbamide Eugia 500 mg, harde capsulesCapsule, hard · Eugia Pharma (Malta) Limited
- Hydroxycarbamide Eureco-Pharma, 500 mg harde capsulesCapsule, hard · Eureco-Pharma B.V.
Canada
Health Canada · 6 registrations
At a glance
- ATC code
- L01XX05
- Registers
- 10
- Historical lists
- 3
- Registrations
- 41
- With their own page
- 36
- Companies
- 29
All medicines with Hydroxycarbamide
Human medicines from every register that match Hydroxycarbamide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
41 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Hydroxycarbamide ERC 500 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Euro Registratie Collectief B.V. | |
| Hydroxycarbamide Eugia 500 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Eugia Pharma (Malta) Limited | |
| Hydroxycarbamide Devatis 500mg, harde capsules | Netherlands | Capsule, hard | Authorised | Devatis GmbH | |
| Hydroxycarbamide Eureco-Pharma, 500 mg harde capsules | Netherlands | Capsule, hard | Authorised | Eureco-Pharma B.V. | |
| Hydroxyurea | United States | 250MG, 500MG | capsule | Marketed | Leading |
| Hydrea | United States | 500MG | capsule | Marketed | Waylis Therap |
| Apo-Hydroxyurea | Canada | 500 MG | Capsule | Marketed | Apotex INC |
| Riva-Hydroxyurea | Canada | 500 MG | Capsule | Marketed | Laboratoire Riva INC. |
| Mylan-Hydroxyurea | Canada | 500 MG | Capsule | Marketed | Mylan Pharmaceuticals Ulc |
| Hidroxicarbamida Medac 500 MG Cápsulas Duras | Spain | 500 mg | cápsula dura | Authorised | Medac Gesellschaft Für Klinische Spezialpräparate Gmbh |
| Hydroxyurea ERC 500 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Euro Registratie Collectief b.v. | |
| Hydroxyurea medac, 500 mg harde capsules | Netherlands | Capsule, hard | Authorised | Medac Gesellschaft für klinische Spezialpräparate mbH | |
| Hydroxyurea | United States | 1GM | tablet | Not marketed | Barr |
| Hidroxicarbamida Hikma 500 MG Capsulas Duras Efg | Spain | 500 mg | cápsula dura | Authorised | Hikma Farmaceutica (Portugal) S.A. |
| Eugia-Hydroxyurea | Canada | 500 MG | Capsule | Authorised | Eugia Pharma INC. |
| Hydrea | Canada | 500 MG | Capsule | Marketed | Cheplapharm Arzneimittel GMBH |
| HYDREA 500 mg CAPSULAS DURAS | Spain | 500 mg | cápsula dura | Marketed | Cheplapharm Arzneimittel Gmbh |
| Siklos | United States | 100MG, 1GM | tablet | Marketed | Theravia |
| Xromi | United States | 100MG/ML | solution | Marketed | Nova Labs LTD |
| Siklos 100 MG Comprimidos Recubiertos con Pelicula | Spain | 100 mg | comprimido recubierto con película | Marketed | Theravia |
| Siklos 1.000 MG Comprimidos Recubiertos con Pelicula | Spain | 1000 mg | comprimido recubierto con película | Marketed | Theravia |
| Siklos | European Union | Authorised | Theravia | ||
| Xromi | European Union | Authorised | Lipomed GmbH | ||
| Droxia | United States | 200MG, 300MG, 400MG | capsule | Not marketed | Waylis Therap |
| Siklos filmomhulde tabletten, 100 mg | Netherlands | Filmomhulde tablet | Authorised | Theravia |